Form 4: Marsh & McLennan Executive Exercises Options and Sells Shares
SEC Form 4
Paul Beswick, SVP and Chief Information Officer of Marsh & McLennan Companies, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 4th and 5th, 2024, Paul Beswick, the SVP and Chief Information Officer of Marsh & McLennan Companies, exercised stock options to purchase 1,000 shares on each day at a price of $118.865 per share.
- Following the exercise of these options, Beswick sold shares of common stock on the open market.
- On March 4th, 1,169 shares were sold at $200.79 per share, and an additional 1,000 shares were sold at $200.79 per share.
- On March 5th, 1,000 shares were sold at $202 per share, and another 1,169 shares were sold at $202 per share.
- These transactions were executed under a pre-existing Rule 10b5-1 trading plan.
- Following these transactions, Beswick directly owns 14,199 shares of Marsh & McLennan Companies common stock and holds options to purchase 6,892 more shares.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by an executive, with no inherent positive or negative sentiment.
Industry Context
Executive stock option exercises and sales are a common occurrence in publicly traded companies and are often part of executive compensation packages. The use of a 10b5-1 trading plan allows insiders to sell shares without being accused of trading on non-public information.
Comparison to Industry Standards
- Executive compensation practices, including stock options, are common across the financial services industry.
- Companies like Aon and Willis Towers Watson also utilize stock options as part of their executive compensation packages.
- The vesting schedules and exercise prices are generally in line with industry standards for similar roles and company sizes.
- The use of Rule 10b5-1 trading plans is a standard practice to mitigate insider trading concerns.
Stakeholder Impact
- The transactions have a minimal impact on shareholders, as they are part of a pre-arranged trading plan and do not indicate a change in the company's fundamentals.
Key Dates
| Date | Description |
|---|---|
| 02/19/2020 | Date the options were granted. |
| 02/19/2021 | First vesting date of the options. |
| 02/19/2022 | Second vesting date of the options. |
| 02/19/2023 | Third vesting date of the options. |
| 02/18/2030 | Expiration date of the options. |
| 03/04/2024 | Date of option exercise and share sale. |
| 03/05/2024 | Date of option exercise and share sale. |
| 03/06/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.